MedPath

Exophthalmometry With 3D Face Scanners

Not Applicable
Conditions
Graves Ophthalmopathy
Orbital Fractures
Exophthalmos
Orbital Tumor
Interventions
Device: Exophthalmos measurement
Registration Number
NCT04704414
Lead Sponsor
University of Zurich
Brief Summary

This study investigates diagnostic methods to measure eyeball protrusion with a smartphone face scanner compared to the traditional Hertel exophthalmometer. The study aims to validate a new reliable, fast and convenient smartphone app to measure the protrusion of the eyeball in different diseases such as Graves' disease, orbital tumors, orbital fractures or orbital inflammation, as well as other rare diseases.

Detailed Description

BACKGROUND: Accurate and reproducible measures of abnormal eyeball protrusion are important for diagnosing different causes of exophthalmos, as well as following patients with Grave's orbitopathy and retroorbital tumors. The current clinical gold standards for measuring abnormal eyeball protrusion is the Hertel exophthalmometer, which is prone to reading errors and inconvenient to use.

OBJECTIVE: The purpose of the EX3D-project is to replace the historic Hertel Exophthalmometer with a state-of-the-art mobile smartphone app that every ophthalmologist can carry in his pocket.

METHODS: The investigators developed an accurate and easy to use method for measuring abnormal eyeball protrusion using the TrueDepth camera of the iPhone 11 in comparison with a high-resolution 3D scanner as a reference to compare with the Hertel Exophthalmometer.

OUTCOMES:

1. Accuracy and precision of 3D face-scanner and iPhone in comparison to Hertel Exophthalmometer.

2. Test re-test reliability in comparison to Hertel Exophthalmometer.

3. Inter-operator reliability against Hertel Exophthalmometer.

4. Patients before and after exophthalmos changing treatment.

5. Applicability in daily clinical practice.

BROADER IMPACT: The invention makes exophthalmometry quick, easy and objective. A mobile smartphone application would replace measurements with the traditional Hertel Exophthalmometer, which are cumbersome, prone to reading errors and have a poor inter-rater reliability as well as test-retest reliability.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Written informed consent
  • Able to cooperate with the study investigations (hearing, comprehension)
  • Exophthalmos (Grave's disease, orbital tumors, orbital inflammation, orbital fractures, rare causes (congenital, e.g. microphthalmos)
  • health controls
Exclusion Criteria
  • Unable to sign informed consent
  • Unable to cooperate with the examinations (hearing loss, neurological deficits)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Validation of smartphone face scannerExophthalmos measurementValidation of smartphone face scanner in comparison to Hertel Exophthalmometer and high-definition face scanner.
Primary Outcome Measures
NameTimeMethod
Test-retest-reliability of the smartphone face scannerOn average 2 weeks

Repeated measures (measured in mm for each eye) of the same subjects with iPhone 11, Hertel Exophthalmometer and 3D face scanner

Accuracy of the smartphone face scannerOn average 2 weeks

Accuracy of iPhone exophthalmos measurements (measured in mm for each eye) compared to measure with 3D face scanner and Hertel Exophthalmometer

Inter-operator reliability of the smartphone face scannerOn average 2 weeks

Measurement (measured in mm for each eye) of the same patients by 3 different operators

Smartphone face scanner measures before and after treatment with the smartphone face scannerOn average 3 months

Measurements (measured in mm for each eye) with the smartphone face scanner before and after exophthalmos-changing treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ophthalmology Department, University Hospital Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath